If anything been proven today, it’s that LTHs make the biggest gains.The key is to be patient on brilliant news like today’s. Next year we could be double if not triple these levels, so does what happens this afternoon really matter?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%